Cargando…

Cancer/testis antigens (CTAs) expression in resected lung cancer

BACKGROUND: Increasing evidence shows cancer/testis antigens (CTAs) play a key role in oncogenesis. Our pre-study finds that MAGEA1, MAGEA10, MAGEB2, KK-LC-1, and CTAG1A/B have high expression frequencies at the protein level. We aim to explore their prognostic role and correlations with clinical ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Shi, Cao, Shoubo, Li, Jianhua, Meng, Qingwei, Wang, Chunyan, Yao, Lei, Lang, Yaoguo, Cao, Jingyan, Shen, Jing, Pan, Bo, Hu, Jing, Yu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078192/ https://www.ncbi.nlm.nih.gov/pubmed/30122941 http://dx.doi.org/10.2147/OTT.S159491

Ejemplares similares

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients
por: Cao, Shoubo, et al.
Publicado: (2016)

Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer
por: Pan, Bo, et al.
Publicado: (2015)

Author Correction: Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer
por: Pan, Bo, et al.
Publicado: (2020)

Reliability of Canadian Emergency Department Triage and Acuity Scale (CTAS) in Saudi Arabia
por: Alquraini, Mustafa, et al.
Publicado: (2015)

An Evaluation of a Modified CTAS at an Accident and Emergency Department in a Developing Country
por: Pooransingh, Shalini, et al.
Publicado: (2018)

IL-17 induces macrophages to M2-like phenotype via NF-κB
por: Shen, Jing, et al.
Publicado: (2018)

Novel Cell and Tissue Acquisition System (CTAS): Microdissection of Live and Frozen Brain Tissues
por: Kudo, Lili C., et al.
Publicado: (2012)

Pediatric Canadian Triage and Acuity Scale (PaedsCTAS) as a Measure of Injury Severity
por: Yates, Morgan Thorn, et al.
Publicado: (2016)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

Inducible expression of antigen processing and antigen presentation molecules and cancer testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2015)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Implementation of the Canadian Emergency Department Triage and Acuity Scale (CTAS) in an Urgent Care Center in Saudi Arabia
por: Arafat, Abdullah, et al.
Publicado: (2016)

Inducible expression of cancer-testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2016)

Comment on Alquraini et al.: reliability of Canadian Emergency Department Triage and Acuity Scale (CTAS) in Saudi Arabia
por: Mirhaghi, Amir
Publicado: (2015)

Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma
por: Noordam, Lisanne, et al.
Publicado: (2021)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
por: Yang, Ping, et al.
Publicado: (2022)

Pattern of cancer/testis antigen expression in lung cancer patients
por: KIM, YEONG-DAE, et al.
Publicado: (2012)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Total Bolus Extraction Method Improves Arterial Image Quality in Dynamic CTAs Derived from Whole-Brain CTP Data
por: Ghariq, Elyas, et al.
Publicado: (2014)

Translation of a scale measuring cognitive test anxiety (G-CTAS) and its psychometric examination among medical students in Germany
por: Stefan, Alexandra, et al.
Publicado: (2020)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
por: Miyamoto, Ai, et al.
Publicado: (2022)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis
por: Rosenzweig, M A, et al.
Publicado: (2012)

Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2015)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
por: Wu, Jing, et al.
Publicado: (2022)

Detection of cancer/testis antigens as a diagnostic tool in routine pathology practice
por: Chen, Yao-Tseng
Publicado: (2014)

Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma
por: Xu, Yingyu, et al.
Publicado: (2023)

Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-κB signaling
por: Zhao, Huan, et al.
Publicado: (2019)

Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
por: Khan, Ghazala, et al.
Publicado: (2015)

Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
por: Mooney, Steven M, et al.
Publicado: (2016)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects()
por: Wei, Xiao, et al.
Publicado: (2019)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
por: Jakobsen, Mie K., et al.
Publicado: (2020)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7r59t7k24ea8reblivdgjl8up